DS-3939a — catalyst calendar
Upcoming
| Date | Event | Company | Drug | Official source & verification |
|---|---|---|---|---|
| 2026-10-20 in 3mo
ESTIMATED |
READOUT
First-in-Human Study of DS-3939a in Participants With Advanced Solid Tumors
Phase 1/2 · Advanced Solid Tumor, Metastatic Solid Tumor |
Daiichi Sankyo | DS-3939a |
ClinicalTrials.gov ↗
✓ Source-checked 2026-08-06
Sponsor-projected date — can change
|